| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9277342 | Enfermedades Infecciosas y Microbiología Clínica | 2005 | 8 Pages |
Abstract
Besides this, new drugs are increasing the three classic antiretroviral families. Among nucleoside analogs emtricitabine (recently marketed) and amdoxovir are the more prominent. Capravirine and TMC-125 are the nonnucleoside analogs whose studies are more advanced. And atazanavir, fos-amprenavir, tipranavir and TMC-114 are the new protease inhibitors recently marketed or near to be.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
José López-Aldeguer, Koldo Aguirrebengoa, José Ramón Arribas, José A. Esté, José MarÃa Kindelán,